Literature DB >> 24940091

Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease.

J A Broomfield, J N Greenspoon, A Swaminath.   

Abstract

Entities:  

Year:  2014        PMID： 24940091      PMCID： PMC4059795          DOI： 10.3747/co.21.1988

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  8 in total

1.  The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.

Authors:  A Sahgal; D Roberge; D Schellenberg; T G Purdie; A Swaminath; J Pantarotto; E Filion; Z Gabos; J Butler; D Letourneau; G L Masucci; L Mulroy; A Bezjak; L A Dawson; M Parliament
Journal:  Clin Oncol (R Coll Radiol)       Date:  2012-05-24       Impact factor: 4.126

Review 2.  Radiotherapy for liver metastases: a review of evidence.

Authors:  Morten Høyer; Anand Swaminath; Sean Bydder; Michael Lock; Alejandra Méndez Romero; Brian Kavanagh; Karyn A Goodman; Paul Okunieff; Laura A Dawson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-01       Impact factor: 7.038

Review 3.  Stereotactic body radiotherapy for oligometastases.

Authors:  Alison C Tree; Vincent S Khoo; Rosalind A Eeles; Merina Ahmed; David P Dearnaley; Maria A Hawkins; Robert A Huddart; Christopher M Nutting; Peter J Ostler; Nicholas J van As
Journal:  Lancet Oncol       Date:  2013-01       Impact factor: 41.316

Review 4.  Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge?

Authors:  Madeleine Carey Sampson; Alan Katz; Louis S Constine
Journal:  Semin Radiat Oncol       Date:  2006-04       Impact factor: 5.934

5.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

6.  Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.

Authors:  Michael T Milano; Alan W Katz; Hong Zhang; Paul Okunieff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-13       Impact factor: 7.038

Review 7.  Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases.

Authors:  Arjun Sahgal; Cari M Whyne; Lijun Ma; David A Larson; Michael G Fehlings
Journal:  Lancet Oncol       Date:  2013-07       Impact factor: 41.316

8.  Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial.

Authors:  David A Palma; Cornelis J A Haasbeek; George B Rodrigues; Max Dahele; Michael Lock; Brian Yaremko; Robert Olson; Mitchell Liu; Jason Panarotto; Gwendolyn H M J Griffioen; Stewart Gaede; Ben Slotman; Suresh Senan
Journal:  BMC Cancer       Date:  2012-07-23       Impact factor: 4.430
  8 in total
  5 in total

Review 1.  Oligometastatic Disease in Upper Gastrointestinal Cancer - How to Proceed?

Authors:  Costanza Chiapponi; Felix Berlth; Patrick S Plum; Christopher Betzler; Dirk L Stippel; Felix Popp; Christiane J Bruns
Journal:  Visc Med       Date:  2017-02-15

Review 2.  [Oligometastasis in pancreatic cancer : Current state of knowledge and spectrum of local therapy].

Authors:  F Gebauer; A I Damanakis; C Bruns
Journal:  Chirurg       Date:  2018-07       Impact factor: 0.955

3.  VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions.

Authors:  R Orecchia; A Surgo; M Muto; A Ferrari; G Piperno; M A Gerardi; S Comi; C Garibaldi; D Ciardo; A Bazani; F Golino; F Pansini; C Fodor; P Romanelli; D Maestri; V Scroffi; S Mazza; B A Jereczek-Fossa
Journal:  Ecancermedicalscience       Date:  2016-09-29

Review 4.  Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.

Authors:  Jin-On Jung; Henrik Nienhüser; Nikolai Schleussner; Thomas Schmidt
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

Review 5.  Multimodal treatment in oligometastatic gastric cancer.

Authors:  Mickael Chevallay; Charles-Henri Wassmer; Pouya Iranmanesh; Minoa K Jung; Stefan P Mönig
Journal:  World J Gastrointest Oncol       Date:  2022-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.